HBV Chronic hepatitis during chemotherapy - an immune controlled disease.
Caruntu
Florin Alexandru
FA
University of Medicine and Pharmacy Carol Davila, Bucharest, National Institute for Infectious Diseases "Prof. dr. Matei Bals" UMF "Carol Davila" Bucharest, Romania. florinc01@xnet.ro
Gheorghita
Valeriu
V
D000465:Algorithms; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002985:Clinical Protocols; D004279:DNA, Viral / Q000097:blood; D004334:Drug Administration Schedule; D006510:Hepatitis B Antibodies / Q000097:blood; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000097:blood / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D012307:Risk Factors; D055502:Secondary Prevention; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D004279:DNA, Viral; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D007166:Immunosuppressive Agents